Machine learning is reshaping discovery science in Human Health and Organicin Scientific is proving its potential in animal health too. Mat Mitchell, Co-Founder and CTO, shares how Organicin Scientific’s machine-learning platform automates candidate selection to identify, evaluate, and commercialise novel antimicrobials for safe and sustainable use across the industry.
Session Topics:
Machine Learning
R&D
Drug Discovery
Antimicrobial
AI
Speaker(s):
Mathew Mitchell
Co-Founder and CTO
Organicin Scientific
Time:
5.15pm - 5.35pm
Agenda Track No.:
Track 2
Summary:
Session Will be Recorded - Attend live or Watch On-Demand
Session Type:
General Session (Presentation)